Cancer-Causing Virus in Vaccines
In 1952, monkey tissue was used to make the polio vaccines, and viruses from the monkeys were present in both the Inactivated Polio Vaccine (IPV) created by Dr. Jonas Salk and the Oral or “Live” Polio Vaccine (OPV) created by Dr. Albert Sabin. Increasing numbers of children with cancer are still testing positive for the SV40 virus today. See Alexander’s Story.
This is the code for the 40th monkey or simian virus found in the vaccines. It has been the most researched contaminant of all the viruses in vaccines, and the one most linked to cancers.
In 1961, SV40 was discovered by Dr. Bernice Eddy of the National Institute of Health when she injected material used to grow polio vaccines into hamsters. Tumors grew in the hamsters. Her discovery was subsequently validated by Drs. Maurice Hilleman, “the most respected of all vaccinologists.”
Outlawed in 1961 but Vaccine Makers Did Not Discard
Upon the discovery that SV40 was an animal carcinogen, a federal law was passed in 1961 that required that no vaccines contain this virus.
However, the manufacturers did not discard SV40 contaminated vaccines or the contaminated seed material. They continued to make vaccines containing SV40 for forty years more!
It has been alleged that there have been SV40-contaminated batches of oral polio vaccine administered to some children until the end of the 1990’s. Source
Recent Research on SV40
Since 1994 Michele Carbone has written more than twenty studies and reviews investigating SV40’s link to human cancer. “There is no doubt that SV40 is a human carcinogen,” he says. “SV40 is definitely something you don’t want in your body.”
Link to Mesothelioma Now Proven
Seventeen major laboratories (in United States, Great Britain, France, Belgium, Italy, and New Zealand) have confirmed Carbone’s research with respect to the presence of SV40 in human mesothelioma. Their results point to a solution to an enigma that long puzzled researchers. SV40 virus is found in most mesotheliomas – a cancer supposedly caused by asbestos exposure.
But at least 20 percent of mesothelioma victims report no asbestos exposure, and only 10 percent of people who have had heavy exposure to asbestos ever develop mesothelioma! Source
Links to Other Cancers…
American Journal of Medicine Article:
“Results establish SV40 is associated significantly with brain tumors, bone cancers, malignant mesothelioma, non-Hodgkin’s lymphoma.”
BACKGROUND: Many studies have reported the presence of simian virus 40 in human brain tumors and bone cancers, malignant mesothelioma, and non-Hodgkin’s lymphoma. However, the small samples and lack of control groups in some reports have made it difficult to assess their reliability.
METHODS: Studies were included in this analysis if they met the following criteria: original studies of patients with primary brain tumors and bone cancers, malignant mesothelioma, or non-Hodgkin’s lymphoma; the investigation of SV40 was performed on primary cancer specimens; the analysis included a control group; and the same technique was used for cases and controls. Included reports were published from 1975 to 2002.
RESULTS: Thirteen studies fulfilled the criteria for the investigation of primary brain cancers (661 tumors and 482 control samples). Specimens from patients with brain tumors were almost four times more likely to have evidence of SV40 infection than were those from controls (odds ratio [OR] = 3.9; 95% confidence interval [CI]: 2.6 to 5.8). The association was even stronger for mesothelioma (OR = 17; 95% CI: 10 to 28; based on 15 studies with 528 mesothelioma samples and 468 control samples) and for bone cancer (OR = 25; 95% CI: 6.8 to 88; based on four studies with 303 cancers and 121 control samples). SV40 DNA was also more frequent in samples from patients with non-Hodgkin’s lymphoma (OR = 5.4; 95% CI: 3.1 to 9.3; based on three studies with 301 cases and 578 control samples) than from controls.
CONCLUSION: These results establish that SV40 is associated significantly with brain tumors, bone cancers, malignant mesothelioma, and non-Hodgkin’s lymphoma. Studies are needed to assess current prevalence of SV40 infections.
Abstract Source: Am J Med. 2003 Jun 1 ;114(8):675-84. PMID: 12798456
Abstract Authors: Regis A Vilchez, Claudia A Kozinetz, Amy S Arrington, Charles R Madden, Janet S Butel
Article Affiliation: Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, BCM 286, Room N1319, One Baylor Plaza, Houston, TX 77030, USA. email@example.com